Rapid advances in the life sciences and technologies, and their diffusion and convergence with other disciplines, hold great promises to improve our health, societies and environment. Emerging and existing technologies can bring transformational opportunities that can play a critical role to support the mission of WHO. However, advances and developments in life sciences and associated technologies can pose risks, including safety and security risks that can cause accidental, unintended or deliberate harm to humans, animals, agriculture and our environment.
In September 2022, WHO issued the Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research. The guidance calls on WHO Member States and other stakeholders to mitigate biorisks and safely govern dual-use research.
This is a global, technical and normative framework for informing the development of national frameworks and approaches for mitigating biorisks and governing dual-use research. The framework is intended as the starting point for the development and strengthening of biorisk management, which relies on three core pillars: laboratory biosafety, laboratory biosecurity and the oversight of dual-use research. The framework raises awareness about the importance of undertaking biorisk management within the context of the One Health approach to optimize the health of people, animals and ecosystems.
Preventing and mitigating these risks is a shared responsibility and involves many stakeholders with different capacities. The TAG-RULS DUR supports WHO in advising Members States and other stakeholders to develop and implement biorisk management in their different contexts.
In its capacity as an advisory body to WHO, the TAG-RULS DUR shall have the following functions:
1. to provide, review and make recommendations to WHO on the scientific, technical and strategic aspects relevant to the monitoring and mitigation of biorisks and advances in the life sciences and related technologies, the governance of dual-use research and the responsible use of the life sciences;
2. to identify gaps, challenges, strengths and opportunities and recommend priorities to WHO and the relevant technical unit – Emerging Technologies, Research Prioritisation and Support (EPS) – on the scientific, technical and strategic aspects relevant to the anticipation, prevention and mitigation of biorisks, the governance of dual-use research and the responsible use of the life sciences;
3. to advise on the work and activities of the WHO project of Ensuring the responsible use of the life sciences: mitigating biorisks and governing dual-use research, part of the EPS unit; and
4. upon request by WHO, to advise WHO on a reporting mechanism relevant to the mitigation of biorisks, the governance of dual-use research and the responsible use of the life sciences.
Following the call for interests, WHO has appointed the 20 members of the TAG-RULS DUR, who serve in their personal capacities to represent the broad range of disciplines relevant to this area of work including but not limited to expertise on:
In the selection of the TAG members, consideration was given to attaining an adequate distribution of technical expertise, geographical representation and gender balance.
Members of the TAG-RULS DUR have been appointed to serve for a period of two years.
Their appointment may be terminated at any time by WHO if WHO's interest so requires or, as otherwise specified in these terms of reference or letters of appointment. Where a member’s appointment is terminated, WHO may decide to appoint a replacement member.
Director & Deputy Registrar, Medical Laboratory Science Council of Nigeria.
Professor and Biosafety Advisor, Animal Health Research Institute, Egypt
Manager of Biotechnology, Innovation, and Novel Sciences section, Science, Reporting and Assessment Directorate, Science and Technology Branch, Government of Canada.
Key Expert, EU Chemical, Biological, Radiological and Nuclear Centers of Excellence Initiative Regional Secretariat for Central Asia.
Professor of Epidemiology at Harvard T.H. Chan School of Public Health, Boston, United States of America.
Director S&T, National Council for Scientific Research and Technologies, Algiers, Algeria
Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals
Senior Principal Research Scientist, Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Principal Research Scientist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO),Australia.
Head, Biosecurity Office at the National Institute of Public Health and the Environment, The Netherlands
A Commissioner in the Government of Uganda and a Visiting Professor at the Department of Community and Public Health, Busitema University.
Deputy Director, Johns Hopkins Center for Health Security
Independent Consultant, former member of the Group of Experts supporting the UN Security Council 1540 Committee on Weapons of Mass Destruction Non-Proliferation.
Professor, Caucasus International University, Georgia
Distinguish Nat. Prof./Prof. Emeritus, Quaid-i-Azam University, Islamabad
Director, Research Center for Biosafety, Laboratory Animal and Pathogen Bank, National Institute of Infectious Diseases (NIID), Japan
Principal Scientist, Defense Science & Technology Laboratory, United Kingdom
Chairperson of the Institutional Biorisk Committee, Primate Research Center and Lecturer, Primatology Graduate Program, Bogor Agricultural University, Indonesia.
Associate professor of international law, Tianjin University School of Law and Center for Biosafety Research &Strategy.
The members of the TAG-RULS DUR must respect the impartiality and independence required of WHO. In performing their work, members may not seek or accept instructions from any government or from any authority external to the Organization. They must be free of any real, potential or apparent conflicts of interest.
To this end, the members have completed a declaration of interests form and their appointment has been subject to the evaluation of completed forms by the WHO Secretariat, determining that their participation will not give rise to a real, potential or apparent conflict of interest.
Notwithstanding the requirement to complete the WHO declaration of interest form, TAG-RULS DUR members have an ongoing obligation to inform the WHO of any interests real or perceived that may give raise to a real, potential or apparent conflict of interest. WHO may, from time to time, request TAG-RULS DUR members to complete a new declaration of interest form. This may be before a TAG-RULS DUR meeting or any other TAG-RULS DUR related activity or engagement, as decided by WHO. Where WHO has made such a request, the TAG-RULS DUR member’s participation in the TAG-RULS DUR activity or engagement is subject to a determination that their participation would not give rise to a real, potential or apparent conflict of interest.
TAG-RULS DUR Secretariat
World Health Organization
Avenue Appia 20
1211 Geneva 27
Switzerland
Email: [email protected]